SAVE THE DATE:
You and your nurse practitioner colleagues are invited to

An AANP 2024 Satellite Symposium on

Early Use of CGM in Type 2 Diabetes — Late-Breaking Trials on CGM-Directed Glycemic Management, Patient Safety, and Resource Utilization Across the Nurse Practitioner Setting
main image

Save the Date and Time
Register Now!

Wednesday, June 26, 2024
5:15 PM – 6:30 PM

Music City Center
Grand Ballroom C2
Nashville, TN 

Enrollment for this
Symposium is
complimentary



An Interactive Case Management and Data-Driven
2024 Technology and Practice Update
for the Nurse Practitioner



For more information: info@cmeducation.net
main image

Save the Date and Time – Register Now!

5:15 PM – 6:30 PM
Music City Center | New Orleans, LA | Grand Ballroom C2

Friday, June 26, 2024

Brochure Cover

Program Agenda


5:15 PM – 5:30 PM

Chair’s Introduction

A Data-Driven Rationale for the Early Deployment of Continuous Glucose Monitoring (CGM)

Late-Breaking Trials and Guidance for Initial Interventions in Type 2 Diabetes

Davida F. Kruger, MSN, APN-BC,BC-ADM – Program Chair
Certified Nurse Practitioner | Henry Ford Health System | Division of Endocrinology, Diabetes, Bone and Mineral Disease | Detroit, MI


5:30 PM – 5:50 PM

The Actionability of the Ambulatory Glucose Profiles (AGP) for Guiding Therapeutic Decisions on T2D

 

Lucia M. Novak, MSN, ANP-BC, BC-ADM
Nurse Practitioner | Board Certified Adult Health and Advanced Diabetes Management | President, Diabesity, LLC | Co-Executive Director, Capital Health & Metabolic Center | Capital Diabetes & Endocrine Associates | Silver Spring, MD





5:50 PM – 6:10 PM 

Applying Technological Advances in CGM to Move Beyond HbA1c in Older Persons with T2D

New Real-World Data Confirming Patient-Centric Preferences for CGM-Based Care in the Primary Provider Setting

Davida F. Kruger, MSN, APN-BC,BC-ADM – Program Chair
Certified Nurse Practitioner | Henry Ford Health System | Division of Endocrinology, Diabetes, Bone and Mineral Disease | Detroit, MI


5:55 PM – 6:15 PM 

Audience-Faculty Interactive Patient Management Sessions: Putting CGM Into Practice in the Real World

Using Individualized AGP/GPIR Reports and Glycemic Metrics to Move Beyond HbA1c to Optimize Health Outcomes in Diabetes

Lucia M. Novak, MSN, ANP-BC, BC-ADM
Nurse Practitioner | Board Certified Adult Health and Advanced Diabetes Management | President, Diabesity, LLC | Co-Executive Director, Capital Health & Metabolic Center | Capital Diabetes & Endocrine Associates | Silver Spring, MD



Program Chair and Faculty

Davida F. Kruger, MSN, APN-BC,BC-ADM – Program Chair

Certified Nurse Practitioner 

Henry Ford Health System 

Division of Endocrinology, Diabetes, Bone and Mineral Disease 

Detroit, MI

Lucia M. Novak, MSN, ANP-BC, BC-ADM

Nurse Practitioner 

Board Certified Adult Health and Advanced Diabetes Management 

President, Diabesity, LLC 

Co-Executive Director, Capital Health & Metabolic Center 

Capital Diabetes & Endocrine Associates 

Silver Spring, MD



Enrollment for this
Symposium is
complimentary


EDUCATIONAL AND LEARNING OBJECTIVES

Upon completion of this activity, participants will be able to:

  • Explain how sensor-based glucose monitoring can be used to improve health metrics in persons with diabetes and obesity
  • Describe new device-based advances in CGM technology, including how to use Glucose Pattern Insight Reports (GPIR) to guide both patient-based behavioral change and clinician-directed interventions in persons with diabetes
  • Discuss the critical importance of continuous glucose monitoring to ensure attainment of glycemic targets—TIR, GV, and HA1c/GMI—in obese patients with Type 2 diabetes, regardless of therapeutic interventions used to lower blood glucose
  • Identify the processes, triggers, and authorization protocols for reimbursement for technologies/devices used for continuous glucose monitoring
  • Illustrate the practice efficiencies and patient education/behavior guidance dimensions of using the Glucose Patterns Insight Report available on some CGM devices
  • Identify a broad range of persons with Type 2 diabetes, including those on oral therapies for obesity, who can potentially benefit from flash continuous monitoring
  • Establish protocols and clinical decision trees for incorporating and implementing sensor-based CGM within the management workflow for diabetes care in the physician associate and primary care settings

TARGET AUDIENCE — WHO SHOULD ATTEND

This Clinical Excellence Summit is directed at the following: nurse practitioners, physician associates, diabetes and endocrinology specialists and researchers and related healthcare providers who manage patients with Type 2 or Type 1 diabetes.

GRANTOR SUPPORT

Supported by an educational grant from Abbott Diabetes Care.

———